Juniper Pharma (JNP) Misses Q1 EPS by 9c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/8/2026

1. LEVI
2. APLD
3. STZ
4. DVN
5. CRGY
6. ZETA
7. ARGX
8. SPY
9. RMR
10. PEP

Go back to Juniper Pharma (JNP) Misses Q1 EPS by 9c

Juniper Pharmaceuticals Reports First Quarter 2015 Financial Results

May 6, 2015 7:01 AM EDT

BOSTON, May 6, 2015 /PRNewswire/ -- Juniper Pharmaceuticals, Inc. (Nasdaq: JNP) ("Juniper" or the "Company"), today announced financial results for the three-month period ended March 31, 2015. First quarter financial highlights include:

Total revenues were $8.3 million, an increase of 19% as compared to $7.0 million in the first quarter of 2014; Product revenues increased 41% year-over-year, enabled by the return of normalized CRINONE® (progesterone gel) shipments to Merck Serono in the fourth quarter of 2014; Service revenues grew 9% year-over-year and 42% from the fourth quarter of 2014, on a local currency basis; Operating profit... More